NEW YORK, Dec. 10 (GenomeWeb News) - ViroLogic will close its $180-million acquisition of Aclara by the end of the day, following requisite stockholder approval. The companies announced the acquisition in June.
Already have a GenomeWeb or 360Dx account?Login Now.
University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.
A new study of a β-thalassemia gene therapy appears promising, according to NPR.
Futurism writes that gene doping could be the next generation of cheating in sports.
In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.